It all scratches the same itch, whether you're building a skincare product, characterizing a novel molecule or writing a song. When you're assembling something, there are certain symmetries and ...

Ventus Therapeutics, a clinical-stage biopharmaceutical company utilizing its proprietary ReSOLVE™ platform to discover and ...

APRIL, a leading skincare and fragrance chain in Israel, secures exclusive rights to Escentric Molecules, a gender-free ...

Pfizer's most advanced candidate, a molecule called danuglipron, has had a rough go at it, with middling efficacy and several ...

One class of drugs has already found success in treating the painful, disorienting and common attacks. Excitement is building about a slew of additional drug targets.

Certain isotopes are unstable and undergo a process of radioactive decay, slowly and steadily transforming, molecule by molecule, into a different isotope. This rate of decay is constant for a ...

Throughout any given year, the National Academies convene hundreds of conferences, workshops, symposia, forums, roundtables, and other gatherings that attract the finest minds in academia and the ...

Fintel reports that on October 31, 2024, Jones Trading initiated coverage of ORIC Pharmaceuticals (NasdaqGS:ORIC) with a Buy ...

In the AstraZeneca case, according to Goodwin’s Big Molecule Watch, the district court granted summary judgment for the government, maintaining that the ability to sell drugs to the Medicare ...

This week got off to a flying start when new science experiments and cargo were launched to the International Space Station, ...

Ixekizumab and apremilast may be an effective treatment among patients with genital psoriasis, with improved disease response and clearance rates.

Evercore ISI analyst Liisa Bayko maintained a Buy rating on BioCryst (BCRX – Research Report) today and set a price target of $10.00. The ...